KFDA to accept industry's revisions on specification and testing methods

The Korea Food and Drug Administration said in a recently held special KGMP surveillance reporting session that it would welcome any revisions on specification and testing methods as part of its efforts to improve the quality of drugs.

Such KFDA's position came as the current specification and testing methods has failed to cope with pharmaceutical firms' more sophisticated production facilit...